ArticleOncotarget2015

The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation.

Wuli Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.